Navigation Links
Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/27/2008

dated Statements of Operations has been

derived from the audited financial statements for the periods

indicated.

Condensed Consolidated Balance Sheet Data

(In thousands)

December 31, December 31,

2007 2006

(Note)

Assets

Cash, cash equivalents and short-term

investments $398,185 $388,825

Accounts receivable 1,901 310

Other current assets 9,162 10,551

Land, property and equipment, net 65,940 56,500

Acquired technology and other non-current assets 12,318 12,279

Total assets $487,506 $468,465

Liabilities and Stockholders' Equity

Accounts payable, accrued expenses and

accrued compensation $30,058 $22,947

Total deferred revenues 4,049 13,054

Total lease financing obligations and other

long-term liabilities 63,100 14,541

Redeemable convertible preferred stock 53,922 51,808

Total stockholders' equity 336,377 366,115

Total liabilities and stockholders' equity $487,506 $468,465

Note: The Condensed Consolidated Balance Sheet Data has been derived from

the audited financial statements as of that date.

Contacts: Jack Lief Mary Claire Duch

President and CEO WeissComm Partners

Media Relations


'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
3. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
4. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
5. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007
7. Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results
8. Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors
10. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
11. Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... (PRWEB) November 27, 2014 Spartan Bioscience ... of Food and Drug Safety (MFDS) regulatory approval for ... provides genetic results in less than 60 minutes from ... indicated as an aid for doctors to determine therapeutic ... pathway. These include some of the world’s most commonly ...
(Date:11/26/2014)... The report on the Global Smart Sensor ... market for revenue forecasts and market trends. It expects ... from 2013 to 2018. At the projected rate, the ... million by 2018. , Browse through the Global Smart ... about the market segmentation and in-depth analysis supported by ...
(Date:11/26/2014)... PHILADELPHIA , Nov. 26, 2014 /PRNewswire-USNewswire/ ... unforgiving environments. Human exploration of space requires astronauts to ... mission safety and success, and prevent potential errors and ... success, little is known about how cognition is affected ... primarily affected. Now, Penn Medicine researchers are ...
(Date:11/26/2014)... NJ (PRWEB) November 25, 2014 ... has officially joined the Morris County (New Jersey) ... which is a leading business organization in the ... opportunity to further engage some key clients in ... operations in the geographic area. Membership enables Whitehouse ...
Breaking Biology Technology:Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs 2Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs 3Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 2Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 3Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 4Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 2Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 3Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 4Whitehouse Laboratories Joins Morris County Chamber of Commerce 2Whitehouse Laboratories Joins Morris County Chamber of Commerce 3
... ... Manufacture and Testing of Drug Products Imported to the European Union. , ... Toronto, Ontario (PRWEB) February ... leading pharmaceutical companies, today announced successful completion of its recent Health Canada audit. The ...
... , FORT LAUDERDALE, Fla. , ... published in EuroIntervention (EuroIntervention, 2010; 5:698-702) demonstrated ... and no late stent thrombosis at one year in ... percutaneous coronary intervention (PCI) and implantation of the company,s ...
... , EMERYVILLE, Calif. , Feb. 1 ... has appointed Ted W. Love , M.D., Executive Vice President ... , M.D., Ph.D., who has served as Interim Chief Medical Officer ... reporting to Dr. Love.   , In his new role, Dr. ...
Cached Biology Technology:Dalton Pharma Services Announces Successful Completion of Health Canada Inspection 2Dalton Pharma Services Announces Successful Completion of Health Canada Inspection 3OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI 2OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI 3Onyx Pharmaceuticals Appoints Ted W. Love, M.D., as Head of Research & Development 2Onyx Pharmaceuticals Appoints Ted W. Love, M.D., as Head of Research & Development 3Onyx Pharmaceuticals Appoints Ted W. Love, M.D., as Head of Research & Development 4Onyx Pharmaceuticals Appoints Ted W. Love, M.D., as Head of Research & Development 5
(Date:11/6/2014)... cancer deaths occur because of metastasis, yet progress ... been slow. , "It,s been particularly challenging to ... Gujral, research fellow in systems biology at Harvard ... detected until after they,ve already metastasized." , Gujral ... that should help researchers better understand how metastasis ...
(Date:11/5/2014)... great diversity in their ability to identify scents and ... in their perceptual evaluation of odors, with women outperforming ... , Sex differences in olfactory detection may play a ... to one,s perception of smell, which is naturally linked ... has been suggested to be cognitive or emotional, rather ...
(Date:11/4/2014)... examining only marketing directed at children on the ... found that the majority of black, middle-income and ... tactics. , Authored by Arizona State University researcher ... the first to examine the use of child-directed ... food restaurants and its relationship to demographics. It ...
Breaking Biology News(10 mins):Migration negation 2Migration negation 3The female nose always knows: Do women have more olfactory neurons? 2Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3
... Manhattan, but no group takes credit. The pressure on ... sketchy information, the president orders an attack, but it ... wrong country. Things go downhill from there. , To ... 12 scientists with extensive nuclear expertise, headed by Stanford ...
... French. , Hunted to near extinction, ... Pacific coast. Their reintroduction, however, is expected to reduce ... shellfish dramatically, such as sea urchins and geoducks. ... an NSERC-funded researcher at the University of British Columbia, ...
... is available in French . , For more ... of Toronto to rev up the production of stem cells and ... embryonic stem cells. The end products are blood and heart cells ... beating tissue. To do this, he has been applying ...
Cached Biology News:Group led by Stanford physicist says there's an urgent need for nuclear detectives 2Group led by Stanford physicist says there's an urgent need for nuclear detectives 3From stem cells to organs: The bioengineering challenge 2
Mouse monoclonal [7B9] to beta II Tubulin ( Abpromise for all tested applications). Antigen: Synthetic peptide, CEEEEGEDEA found at the c-terminus of beta II tubulin. Entrez GeneID: 10383 ...
Gridded Cell Culture Petri Dish (20 mm molded in base), tissue-culture treated...
...
...
Biology Products: